Dutasteride Solid Dispersion Coprecipitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Dutasteride's poor solubility and stability in existing formulations lead to issues such as delayed dissolution and storage instability, and the use of organic solvents and stabilizers like ethanol and butylated hydroxytoluene poses health risks.
Innovation Solution
A solid dispersion of dutasteride is created using a coprecipitate of dutasteride and a water-soluble polymeric carrier, combined with an adsorbent, and optionally a surfactant and plasticizer, to enhance solubility and dissolution rate without using harmful solvents or stabilizers, achieved through a method involving heating and cooling of the polymeric carrier with dutasteride and subsequent adsorption onto an adsorbent.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If soft capsule preparations are used to improve dutasteride solubility, then dissolution rate is improved, but storage stability deteriorates due to gelatin sensitivity to heat and moisture
Solution Approach 1:
The invention changes the physical state of dutasteride from crystalline to amorphous form through solid dispersion technology, fundamentally altering its solubility characteristics. The amorphous state provides high solubility comparable to liquid preparations while enabling stable solid formulation storage without gelatin encapsulation
Solution Approach 2:
The invention creates a composite solid dispersion system combining dutasteride with water-soluble polymers (such as polyvinylpyrrolidone, hydroxypropyl methylcellulose) and adsorbents (such as silicified microcrystalline cellulose, silicon dioxide). This composite structure maintains high dissolution rate while providing storage stability without requiring gelatin soft capsules
2Stability of the object's composition
If stabilizers like butylated hydroxytoluene are added to prevent oxidation and hydrolysis, then stability is improved, but health safety deteriorates due to potential cancer and asthma risks
Solution Approach 1:
The invention extracts and eliminates harmful stabilizers such as butylated hydroxytoluene from the formulation. Instead of using chemical stabilizers that pose health risks, the invention relies on the inherent stability of the solid dispersion system and physiological-safe antioxidants like vitamin E when absolutely necessary
Solution Approach 2:
The invention replaces long-term stabilizers with short-term protective measures using physiologically-safe antioxidants only when needed, rather than relying on persistent chemical stabilizers that accumulate in the body
3Speed
If solubilizing agents in oily liquid form are used to improve solubility, then dissolution is improved, but ease of manufacture deteriorates due to heavy burden in digestion and uptake
Solution Approach 1:
The invention substitutes mechanical solubilization using oily liquids with a molecular-level solid dispersion system. The amorphous dutasteride molecules are dispersed at the molecular level within the polymer matrix, providing solubility enhancement without requiring heavy oily vehicles that burden the digestive system
4Speed
If ethanol is used as a solvent to improve solubility, then dissolution rate is improved, but stability deteriorates due to accelerated formation of related substances
Solution Approach 1:
The invention changes the solvent system from organic ethanol to water-based systems during the solid dispersion preparation process. This parameter change eliminates ethanol-induced crystallinity alterations and prevents accelerated formation of related substances while maintaining high dissolution rate through amorphous formulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solid dispersion exhibits a dissolution rate comparable to or exceeding soft capsules, with improved storage stability and minimal related substances, while avoiding the use of harmful substances.
Implementation Method 1
heating and cooling of the polymeric carrier with dutasteride
Implementation Method 2
a coprecipitate including dutasteride and a water-soluble polymeric carrier
Implementation Method 3
an adsorbent, wherein the dutasteride and the water-soluble polymeric carrier are present in a weight ratio of 1:10-100 in the coprecipitate
Data Source
AI summary
A solid dispersion of dutasteride for improving the solubility or dissolution rate of poorly soluble dutasteride, a method for preparing the solid dispersion, and a pharmaceutical composition including the solid dispersion are provided. The solid dispersion includes: a coprecipitate including dutasteride and a water-soluble polymeric carrier; and an adsorbent. The dutasteride and the water-soluble polymeric carrier are present in a weight ratio of 1:10-100 in the coprecipitate.